Neuroprotective effect of Kurarinone against corticosterone‐induced cytotoxicity on rat hippocampal neurons by targeting BACE1 to activate P13K–AKT signaling – A potential treatment in insomnia disorder

Abstract The hippocampus has been implicated in the pathogenesis of insomnia disorder (ID) and the purpose of this study was to investigate the neuroprotective mechanism of the natural flavone Kurarinone (Kur) on hippocampal neurotoxicity as a potential treatment of ID. The effect of Kur on hippocam...

Full description

Bibliographic Details
Main Authors: Guoqing Wu, Yanyan Wu
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.1132
_version_ 1797658888097497088
author Guoqing Wu
Yanyan Wu
author_facet Guoqing Wu
Yanyan Wu
author_sort Guoqing Wu
collection DOAJ
description Abstract The hippocampus has been implicated in the pathogenesis of insomnia disorder (ID) and the purpose of this study was to investigate the neuroprotective mechanism of the natural flavone Kurarinone (Kur) on hippocampal neurotoxicity as a potential treatment of ID. The effect of Kur on hippocampal neuronal cell (HNC) viability and apoptosis were assessed by Cell counting kit‐8 (CCK‐8) assay and flow cytometry, respectively. Then, the effect of Kur on β‐site amyloid precursor protein‐cleaving enzyme 1 (BACE1), brain‐derived neurotrophic factor (BDNF), and phosphatidylinositol‐3‐kinase (PI3K)/protein kinase B (AKT) phosphorylation level were measured by Western blot. Further, SwissTargetPrediction analysis and molecular docking experiments were used to detect a potential target of Kur. Then, the p‐chlorophenylalanine (PCPA) model was established in vivo to further study the effect of BACE1 expression on Kur and HNC. As a result, HNC viability was only significantly decreased by 2 μM of Kur. Kur reversed the impacts of corticosterone upon inhibiting viability (0.25–1 μM), PI3K (0.5–1 μM)/AKT phosphorylation, and BDNF (1 μM) level, and enhancing the apoptosis (0.25–1 μM) and BACE1 expression (1 μM) in HNCs. BACE1 was a potential target of Kur. Notably, Kur (150 mg/kg) attenuated PCPA‐induced upregulation of BACE1 expression in rat hippocampal tissues as ZRAS (0.8 g/kg). The effects of Kur (1 μM) on corticosterone‐treated HNCs were reversed by BACE1 overexpression. Collectively, Kur downregulates BACE1 level to activate PI3K/AKT, thereby attenuating corticosterone‐induced toxicity in HNCs, indicating that Kur possibly exerted a neuroprotective effect, which providing a new perspective for the treatment of insomnia disorders.
first_indexed 2024-03-11T18:05:49Z
format Article
id doaj.art-22c8d7a68d134e38828c248b07867754
institution Directory Open Access Journal
issn 2052-1707
language English
last_indexed 2024-03-11T18:05:49Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series Pharmacology Research & Perspectives
spelling doaj.art-22c8d7a68d134e38828c248b078677542023-10-17T07:30:29ZengWileyPharmacology Research & Perspectives2052-17072023-10-01115n/an/a10.1002/prp2.1132Neuroprotective effect of Kurarinone against corticosterone‐induced cytotoxicity on rat hippocampal neurons by targeting BACE1 to activate P13K–AKT signaling – A potential treatment in insomnia disorderGuoqing Wu0Yanyan Wu1Department of Medicine Tongde Hospital of Zhejiang Province Hangzhou ChinaDepartment of Medicine Tongde Hospital of Zhejiang Province Hangzhou ChinaAbstract The hippocampus has been implicated in the pathogenesis of insomnia disorder (ID) and the purpose of this study was to investigate the neuroprotective mechanism of the natural flavone Kurarinone (Kur) on hippocampal neurotoxicity as a potential treatment of ID. The effect of Kur on hippocampal neuronal cell (HNC) viability and apoptosis were assessed by Cell counting kit‐8 (CCK‐8) assay and flow cytometry, respectively. Then, the effect of Kur on β‐site amyloid precursor protein‐cleaving enzyme 1 (BACE1), brain‐derived neurotrophic factor (BDNF), and phosphatidylinositol‐3‐kinase (PI3K)/protein kinase B (AKT) phosphorylation level were measured by Western blot. Further, SwissTargetPrediction analysis and molecular docking experiments were used to detect a potential target of Kur. Then, the p‐chlorophenylalanine (PCPA) model was established in vivo to further study the effect of BACE1 expression on Kur and HNC. As a result, HNC viability was only significantly decreased by 2 μM of Kur. Kur reversed the impacts of corticosterone upon inhibiting viability (0.25–1 μM), PI3K (0.5–1 μM)/AKT phosphorylation, and BDNF (1 μM) level, and enhancing the apoptosis (0.25–1 μM) and BACE1 expression (1 μM) in HNCs. BACE1 was a potential target of Kur. Notably, Kur (150 mg/kg) attenuated PCPA‐induced upregulation of BACE1 expression in rat hippocampal tissues as ZRAS (0.8 g/kg). The effects of Kur (1 μM) on corticosterone‐treated HNCs were reversed by BACE1 overexpression. Collectively, Kur downregulates BACE1 level to activate PI3K/AKT, thereby attenuating corticosterone‐induced toxicity in HNCs, indicating that Kur possibly exerted a neuroprotective effect, which providing a new perspective for the treatment of insomnia disorders.https://doi.org/10.1002/prp2.1132BACE1hippocampal neuron cytotoxicityinsomniaKurarinonePI3K/AKT signaling
spellingShingle Guoqing Wu
Yanyan Wu
Neuroprotective effect of Kurarinone against corticosterone‐induced cytotoxicity on rat hippocampal neurons by targeting BACE1 to activate P13K–AKT signaling – A potential treatment in insomnia disorder
Pharmacology Research & Perspectives
BACE1
hippocampal neuron cytotoxicity
insomnia
Kurarinone
PI3K/AKT signaling
title Neuroprotective effect of Kurarinone against corticosterone‐induced cytotoxicity on rat hippocampal neurons by targeting BACE1 to activate P13K–AKT signaling – A potential treatment in insomnia disorder
title_full Neuroprotective effect of Kurarinone against corticosterone‐induced cytotoxicity on rat hippocampal neurons by targeting BACE1 to activate P13K–AKT signaling – A potential treatment in insomnia disorder
title_fullStr Neuroprotective effect of Kurarinone against corticosterone‐induced cytotoxicity on rat hippocampal neurons by targeting BACE1 to activate P13K–AKT signaling – A potential treatment in insomnia disorder
title_full_unstemmed Neuroprotective effect of Kurarinone against corticosterone‐induced cytotoxicity on rat hippocampal neurons by targeting BACE1 to activate P13K–AKT signaling – A potential treatment in insomnia disorder
title_short Neuroprotective effect of Kurarinone against corticosterone‐induced cytotoxicity on rat hippocampal neurons by targeting BACE1 to activate P13K–AKT signaling – A potential treatment in insomnia disorder
title_sort neuroprotective effect of kurarinone against corticosterone induced cytotoxicity on rat hippocampal neurons by targeting bace1 to activate p13k akt signaling a potential treatment in insomnia disorder
topic BACE1
hippocampal neuron cytotoxicity
insomnia
Kurarinone
PI3K/AKT signaling
url https://doi.org/10.1002/prp2.1132
work_keys_str_mv AT guoqingwu neuroprotectiveeffectofkurarinoneagainstcorticosteroneinducedcytotoxicityonrathippocampalneuronsbytargetingbace1toactivatep13kaktsignalingapotentialtreatmentininsomniadisorder
AT yanyanwu neuroprotectiveeffectofkurarinoneagainstcorticosteroneinducedcytotoxicityonrathippocampalneuronsbytargetingbace1toactivatep13kaktsignalingapotentialtreatmentininsomniadisorder